Diarrhea affected 24% of the highest dose group, typically presenting during the first four to six weeks of treatment
Elevated levels indicate liver cell damage
This, however, does not apply to other GLP-1RAs approved for the treatment of T2DM, including the same liraglutide (Victoza) and semaglutide (Ozempic or Rybelsus) at lower dosages, prompting several stakeholders to request an updated guidance 232 and more caution in media enthusiasm 233
Side effects such as nausea or stomach upset are common at first but usually decrease over time
Foundational meta-analyses established this bidirectional association [16], and large-scale registry data confirm that the risk is particularly pronounced in metabolically unhealthy obesity [17]
Talk with your healthcare provider or registered dietitian to personalize your plan and achieve your goals.